Osamu Kunii, CEO of the GHIT Fund, and leaders of globally active companies will engage in a dialogue about solutions to global health issues and the role Japan should play in this area. This dialogue was featured as a collaborative article in Forbes JAPAN.

For the second edition in 2025, we invited Jeremy Grossas, President and Representative Director of Merck Biopharma Co., Ltd., an affiliate of Merck KGaA, Darmstadt, Germany, who advocates for “health equity”, to discuss the ideal shape of sustainable collaboration and partnership in global health.

Forbes JAPAN x GHIT Fund collaboration page (only in Japanese)

Read the article from the link below:

Forbes JAPAN BrandVoice (only in Japanese)